TFS was selected by this small European biotech company to develop provide full service support during the development of their genetically modified bacteria producing human proteins for improving wound healing….
Read More
TFS was selected by this small European biotech company to develop provide full service support during the development of their genetically modified bacteria producing human proteins for improving wound healing….
Immuno-oncology (I-0) has emerged as a promising area of research in oncology. The diverse investigational products that are currently under development in both the United States and the European Union…